biotech / news / / SiliconANGLE News
Novo Nordisk A/S has teamed up with OpenAI to use AI to speed up drug development.
OpenAI will embed its intelligent agents across Novo Nordisk's entire drug development and distribution workflows.
KEY POINTS
- Novo Nordisk will access OpenAI’s most advanced frontier models to analyze massive biological datasets.
- The partnership includes direct AI training for Novo Nordisk employees to boost company-wide AI literacy.
- AI will be used to simulate lab experiments, predicting drug efficacy before physical samples are created.
- A strict data governance framework with human oversight will be established to ensure ethical AI use.
COMPANIES
Summarized by Newsio from SiliconANGLE News. How we summarize →